|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.39 USD | -5.97% |
|
-4.25% | +19.70% |
Company Valuation: Bruker Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 12,725 | 10,053 | 10,170 | 8,887 | 7,158 | 8,584 | - | - |
| Change | - | -21% | 1.17% | -12.62% | -19.45% | 19.92% | - | - |
| Enterprise Value (EV) 1 | 12,991 | 10,627 | 10,964 | 10,798 | 8,728 | 10,064 | 9,853 | 9,754 |
| Change | - | -18.2% | 3.17% | -1.51% | -19.16% | 15.31% | -2.1% | -1.01% |
| P/E ratio | 46.4x | 34.3x | 25.3x | 77.1x | -314x | 55.7x | 42.3x | 28.5x |
| PBR | 12x | 9x | 7.75x | 4.99x | - | 3.41x | 3.24x | 2.56x |
| PEG | - | 3.45x | 0.6x | -1x | 3x | -0x | 1.3x | 0.6x |
| Capitalization / Revenue | 5.26x | 3.97x | 3.43x | 2.64x | 2.08x | 2.39x | 2.3x | 2.18x |
| EV / Revenue | 5.37x | 4.2x | 3.7x | 3.21x | 2.54x | 2.8x | 2.64x | 2.47x |
| EV / EBITDA | 24.9x | 19.1x | 17.9x | 17.9x | 16.4x | 15.4x | 13.6x | 12.1x |
| EV / EBIT | 27.6x | 21x | 20.1x | 20.8x | 20.2x | 18.6x | 16.2x | 14.2x |
| EV / FCF | 68.2x | 73.2x | 45.1x | 80.7x | 202x | 43.7x | 29.9x | 23.4x |
| FCF Yield | 1.47% | 1.37% | 2.22% | 1.24% | 0.5% | 2.29% | 3.35% | 4.27% |
| Dividend per Share 2 | 0.16 | 0.2 | 0.2 | 0.2 | - | 0.2 | 0.2035 | 0.2047 |
| Rate of return | 0.19% | 0.29% | 0.27% | 0.34% | - | 0.35% | 0.36% | 0.36% |
| EPS 2 | 1.81 | 1.99 | 2.9 | 0.76 | -0.15 | 1.013 | 1.333 | 1.98 |
| Distribution rate | 8.84% | 10.1% | 6.9% | 26.3% | - | 19.7% | 15.3% | 10.3% |
| Net sales 1 | 2,418 | 2,531 | 2,964 | 3,366 | 3,436 | 3,589 | 3,739 | 3,943 |
| EBITDA 1 | 521.9 | 556.5 | 614.1 | 602.6 | 532.2 | 654.2 | 726.3 | 802.8 |
| EBIT 1 | 470.2 | 505.6 | 546.3 | 518 | 433.1 | 540.1 | 607 | 685.2 |
| Net income 1 | 277.1 | 296.6 | 427.2 | 113.1 | -22.5 | 154.9 | 203.2 | 306.9 |
| Net Debt 1 | 266 | 573.7 | 793.2 | 1,911 | 1,570 | 1,480 | 1,269 | 1,170 |
| Reference price 2 | 83.91 | 68.35 | 73.48 | 58.62 | 47.11 | 56.39 | 56.39 | 56.39 |
| Nbr of stocks (in thousands) | 151,655 | 147,083 | 138,411 | 151,598 | 151,941 | 152,226 | - | - |
| Announcement Date | 11/02/22 | 09/02/23 | 13/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 55.67x | 2.8x | 15.38x | 0.35% | 8.58B | ||
| 23.68x | 4.33x | 16.67x | 0.39% | 176B | ||
| 46.35x | 12.16x | 27.24x | -.--% | 149B | ||
| 29.2x | 5.47x | 17.06x | 0.78% | 130B | ||
| 17.78x | 3.65x | 11.77x | -.--% | 72.16B | ||
| 30.65x | 6.82x | 21.68x | -.--% | 49.5B | ||
| 18.35x | 2.11x | 10.81x | 2.86% | 44.89B | ||
| 44.28x | 6.22x | 19.14x | -.--% | 35.87B | ||
| 14.43x | 1.62x | 9.06x | 0.24% | 29.42B | ||
| 18.5x | 4.85x | 12.21x | 1.24% | 28.31B | ||
| Average | 29.89x | 5.00x | 16.10x | 0.59% | 72.44B | |
| Weighted average by Cap. | 29.73x | 6.10x | 18.04x | 0.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- BRKR Stock
- Valuation Bruker Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















